# Setmelanotide: First Approval.

> PubMed lists PMID 33638809 in Drugs as Journal Article, Review, with publication-date metadata of 2021-02 (month precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-33638809-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-10-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-33638809-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-33638809-setmelanotide-v1.json
- Content SHA-256: `32364594bfd5631f1782334d1d5e270c3d7428d307a4936717e5c9e33dcdf308`

## Claims and source pins

### Headline

Setmelanotide: First Approval. ([`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`](#source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8))

### Summary

PubMed lists PMID 33638809 in Drugs as Journal Article, Review, with publication-date metadata of 2021-02 (month precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`](#source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8))

### Paragraph 1

PubMed lists PMID 33638809 in Drugs as Journal Article, Review, with publication-date metadata of 2021-02 (month precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`](#source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`](#source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8))

## Sources

<a id="source-pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8"></a>
- **Setmelanotide: First Approval. · retained source version 1:2021-10-11:current:afa3d97ef8b8c9f411fecf06faee8e28eec64902803b9da85eb39f413fe7b596** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/33638809/) (`pubmed-observation-pmid-33638809-2021-10-11-afa3d97ef8b8`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Setmelanotide: First Approval." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-33638809-setmelanotide-v1.json SHA-256: 32364594bfd5631f1782334d1d5e270c3d7428d307a4936717e5c9e33dcdf308.